Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Anthony Hunt currently holds 15,046 shares of REPLIGEN CORP (RGEN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anthony Hunt has been a net seller of RGEN stock. They have purchased $248.2K and sold $84.0M worth of shares.
Anthony Hunt's most recent insider trade was on Feb 24, 2026, when they sold 8,170 shares at $0.00 per share.
Anthony Hunt serves as Executive at REPLIGEN CORP (RGEN). They have executed 197 insider transactions totaling $84.3M over their tenure at the company.
Anthony Hunt holds the position of Executive at REPLIGEN CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Anthony Hunt has shown a selling trading pattern, with $248.2K in total purchases and $84.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Anthony Hunt was on Sep 10, 2025, when they sold $1.8M worth of RGEN shares. This transaction involved 14,882 shares at $120.19 per share.
Anthony Hunt currently owns 15,046 shares of REPLIGEN CORP (RGEN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Anthony Hunt's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Anthony Hunt has 197 Form 4 filings on record as an insider at REPLIGEN CORP.
Set alerts for Anthony Hunt and 40,000+ other insiders.